Sofia Reyes
Health & Nutrition Writer
Sofia covers where peptide research meets daily habits: appetite, meals, sleep, and routine. She spent years writing consumer nutrition guides before joining LifeConverted.
Experimental Injection Destroys Fat Cells in Early Trials
An injectable compound called CBL-514 triggered fat cell death and shrank visceral fat in phase 2 trials, researchers reported.
MK-677 (Ibutamoren) Research Overview: What Studies Show About This Oral Growth Hormone Secretagogue
A research based look at MK-677, its mechanism as a ghrelin receptor agonist, and what trials show about body composition, sleep, and bone.
Semaglutide Study Links GLP-1 Therapy to Fewer Inflammatory Monocytes
A new report suggests semaglutide may lower bone marrow output of inflammatory monocytes in people with type 2 diabetes.
ARA-290 Research Overview: Exploring a Peptide's Role in Nerve and Tissue Repair
A research overview of ARA-290, an erythropoietin derived peptide studied for nerve protection and tissue repair without raising red blood cell counts.
FDA Tightens Rules on Compounded GLP-1 Drugs
FDA says tirzepatide's shortage is over and clarifies when compounded GLP-1 products still qualify for legal exemptions.
Tesamorelin: An Approved GHRH Analog Explained
Tesamorelin is an FDA approved GHRH analog studied for HIV associated fat buildup and body composition changes.
FDA Approves Foundayo, the First Daily Oral GLP-1 Pill
The FDA approved Foundayo, orforglipron, the first oral GLP-1 pill with no food or water timing rules.